Finally, to test whether the most important known human oxygen sensor, PHD2, might serve as a target/biomarker for metabolic disease in humans, we determined if there was any association between serum PHD2 levels and metabolic syndrome traits. The gene discussed is EGLN1; the disease is metabolic disease.